Narratives and emotion drive the market in the short term, so last week we saw the tech stocks and COVID winners take another surge higher, perhaps in some surge of “election finally done” relief or just from the indications of a likely split government ahead… this week, some combination of Joe Biden’s election victory being […]
Articles
Kind of seems like everyone wants to run away and hide until after the election, no? I can’t emphasize enough just how happy I am that this will all be over a week from now… or, at least, that the voting and the initial results will be over, I hope the polls are correct and […]
The plan for today? Figure out what other name might be associated with Nikola Tesla, and use it as the name for a new-age company. Venture funding should flow without regard to merit, and you might just be able to go straight to an IPO and buy that private island. Nikola (NKLA) is taken, thanks […]
We’re used to seeing biotech stocks surge because of the results of a clinical trial… but it’s quite crazy to see the whole market pinning its hopes on a clinical trial. Gilead’s (GILD) Remdisivir had some weak results leak last week and that helped inspire the market selloff (“Oh no, we won’t get a drug […]
Here’s my soothsaying bit for this week, which you should feel free to ignore — like everyone else who’s predicting the future, I’m probably going to be wrong. I don’t think, even now, that we’re pricing in even the bad news that is already almost certain this year… or if we are, we’re pricing in […]
Today I thought I’d answer a reader question about a teaser that’s of particular interest to me — not because it’s particularly heavily marketed, I haven’t even seen the original ad or article our reader cites, but because I like the topic. Here’s the question posted by Irregular bunion132 recently: In a recent piece entitled […]
So… what’s happening this week? I have a few updates on Real Money Portfolio investments, including some updates following earnings releases this week and some notes about my hedge position, as well as some thoughts on a few insurance companies that are catching my eye and making their way onto the watchlist… and I also […]
Odd rolls of the dice here at Gumshoe HQ have led to three different Cabot teaser pitches being covered in a relatively short period of time… this one is an insurance stock, and it has generated quite a few questions from the “teaser article” Cabot sent around saying this secret, unnamed stock is the one […]
Things will be a little quiet here at Stock Gumshoe for the next week or so — I’m off to do my big fundraising ride for Dana-Farber tomorrow, and will then be taking several days off to recuperate next week and spend time with family… I’ll be back with the Friday File next week, but […]
Time for some “Idea of the Month” thoughts for you, dear Irregulars. When you think the investing climate is a little more nerve-wracking than usual, why not go with a master investor who’s also nervous and is preparing for an awful economy? I’ve spoken quite a few times about my fondness for insurance company stocks. […]
Quite a few of our readers have sent in questions about this ad over the last day or two, which actually gives me a bit more hope for humanity — after all, this kind of promise of a “wealth compounding machine” should be much more compelling than the high-risk, highly-speculative “Double in a week” ideas […]
The second day of the Value Investing Congress resulted in mostly headlines about David Einhorn shorting Chipotle (CWG), since that was the only thing he shared that seemed new and sexy, but he and several other presenters also shared some interesting thoughts that stood out for me about a few of the victims/villains of the […]
I can’t think of anything intelligent to say about the current political and Wall Street mess, other than that in times like these I tend to hunker down and slow my trading, and focus more and more on multi-year investments in companies that I’m pretty sure will thrive in the next decade regardless of where […]
Now this one sounds exciting, eh? I don’t want to say that the mighty, mighty Gumshoe is a lazy man, but I must admit that the idea of a work week that lasts only ten minutes has some appeal … what the heck are they talking about? It’ll take me longer than ten minutes, but […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
AS of Aug 15, the newsletter pitch is the same, something happening soon, Dylan says: https://go.behindthemarkets.com/li...
Latest News by Jeff Brown, “FDA Fast Tracks $6.8 Billion Miracle Antibiotic for July Approval One microcap owns the ...
I assume you mean Jeff Brown, no? Not Jeff Bezos (of Amazon)? Brown has indeed been touting Editas for a long time...
I'll be the first to admit I've taken some long shots over the years, the most recent being CRNT. Hopefully, CRNT will b...
Thank you for your thoughtful detailing on the processes currently underway and in realignment in the scale of time invo...
Unravelling mystery of how, when DNA replicates https://www.sciencedaily.com/releases/2018/12/181227150644.htm Have an a...
Thanks MJ, This is the real reason I read stockgumshoe.Having worked in the “Health care” profession for decad...
Cancer treatment and info on this company stock symbol. What is crispr company stock symbol? Thank you! Greatly appreci...
Drug companies cant touch this tech, without paying DEARLY for licensing. CRISPR tech is getting to the root of the pro...
There've been a lot of uncertainties around the CRISPR companies, but I think right now the elephant in the room is the ...
Many highly interesting comments for which many thanks. I will attempt to respond (& perhaps actually answer) to as ma...
You failed to mention advancements covering the efficacy of CRISPR technology...
It's got to be one of the three small biotechs that have access to CRISPR - Crispr Therapeutics (CRSP), Intellia Therape...
Good plan, Dave. I'm 58, do not have time to GAMBLE with hard-earned cash. DRIP plans invested in solid companies tha...
A good perspective. And when it comes to Sangamo, it seems to me that Zinc Finger "editing" is 10-20 years ahead of CRI...
CRISPR might eventually be able to edit the human genome safely, but we are years away from that, assuming scientificall...
So the Big Parma influenced FDA is going to cut the throat of the medical mafia, which is almost 20% of our GDP, by sanc...
It’s Editas, MIT and Harvard have been in a patent battle with Berkeley and Berkeley lost. It’s my understanding th...
Crispr, CRSP, EDIT, NTLA are all promising companies, as is Beam Therapeutics (private company)....
I have recently become aware of two books, 'The Telomerase Revolution' by Dr. Michael Fossel and 'A Crack In Creation' b...
Well, this one would have been a pretty good buy... having doubled since the promotional piece was written. The other cr...
$YTEN, $CLXT fp & #CRISPR stocks... Eatin' CRISPR food in 5 years maybe https://www.ozy.com/fast-forward/you-could-b...
Those are certainly the primary CRISPR names that get teased all the time, though I haven't looked at that actual ad yet...
$JNJ, $GILD, #EDIT etc. - As gene editing explodes, a new report from Goldman says Chinese groups are seizing the lead o...
Regarding CRISPR technology, Has anyone investigated the NEXGEN teaser about a $200 biotech stock that could reach 1 mil...
Market analysts believe that the patent dispute will conclude in the most common way observed in the past cases – both...
I wouldn't put too much credence in the Fool's CRISPR doomsayer act. The paper cited by the Fool suggests ways around th...
Hi John, Here's a couple of articles on the concern: Arbor Biotechnologies Discovers New CRISPR System Utilizing its ...
backoffice, According to The Motley Fool, almost all CRISPR stocks are headed to 0. Not sure that I agree with their...
There are a lot of rare/orphan diseases that no big pharma companies will touch that could be impacted by CRISPR technol...
Ha!! Caught again - thank you for being the best detective on Market Street....
CRISPR is a research tool/technique, not a drug. The first uses of CRISPR in humans are just beginning with initial cli...
Readers may be interested in looking at the January 2018 JP Morgan Healthcare presentation by SGMO. Their gene editing ...
I like instead the company Sangamo (SGMO). Their gene editing technology (zinc finger) appears more robust and safer th...
The technology, research and development behind the three forerunners on the CRISPR gene editing front is so hyped that ...
Incidentally, this patent fight between the major CRISPR "discovery" researchers and their respective institutions does ...
Yes, its Editas (EDIT). But the patent dispute was resolved a year ago. Not new news. They do have a good proprietary...
When I checked the worth of each company mentioned above I found that a smaller company may also be involved in the actu...
Please see following article: "Court Rules Against Berkeley CRISPR Patent (//www.investopedia.com/news/court-rules-again...
$CAPR, the rest of the market and institutions have no faith in CAPR. What could go wrong here. Besides it's one of the ...
I looked into SGNO and their method of zinc fingers seems to have had successful tests so far and they eluded that CRISP...
$CLLS - Two Issued U.S. Patents Granted to Cellectis for CRISPR Use in T-Cells http://www.cellectis.com/en/press/two-i...
$NoTicker...maybe $CRISPR? Cooking this week has been rough. Several bad slices and almost lost a finger tip. I hope ...
$GeneEditing $CRISPR Beautiful. Thank you!...
$GeneEditing $CRISPR “CRISPR gene-editing systems 3D animation (video)” #Fantastic Video - watch what it actu...
The Chart of the Day belongs to CRISPR Therapeutics (CRSP). I found the Biomedical stock by using Barchart to sort toda...
$DFFN in & swingin' - 8K & exhibits filed with the SEC http://www.snl.com/Cache/c391818209.html view all docz http://in...
Goldman: Setting the stage for oncology M&A in 2018 Tax reform unlocks ~$160bn ex-US cash for potential M&A Potential ...
#CRISPR - Crispr Therapeutics AG (NASDAQ: $CRSP) was the recipient of unusually large options trading on Thursday. In...
CrIspr Disappointing. Dreams dashed of becoming hollywood tv gameshow host if I'm immune, and they can't switch off a...
#ARTH out but decided to begin getting back in with some lifting of the haze; #conference call: Just a quick monster t...
Uh Oh—CRISPR Might Not Work in People A sampling of human blood has turned up a surprise: most people could be ...
Doc/Cleveland/Helen others- as a relatively new member of the community I can't tell you how much your deep insight has ...
#GeneTherapy #CRISPR #DMD Interesting article from the MIT Technology Review about CRISPR and Gene Therapy both in gene...
This Startup Has a New CRISPR Enzyme - And Says It Will Give It Away For Free https://www.forbes.com/sites/matthewherper...
Changes to NBI and thus to IBB. The changes reflect equity relevance in the market: Added: Arbutus (NASDAQ:ABUS), Acl...
Read an article on Yahoo Finance recently from the Motley Fool talking about Disruptor Stocks. While no mention of CRIS...
God Key = CRISPR Comapnies holding ip's - Intellia, CRISPR Therapeutics and Editas...
To the best of my knowledge, Editas, Dr Church's company (EDIT) has the sole CRISPR license from the Broad Foundation, a...
Sangamo (SGMO)uses zinc fingers which appears to have an advantage over CRISPR. More precise....
Eiger BioPharmaceuticals isn't a gene therapy company, from what I can tell, though there are certainly plenty of gene t...
CRISPR is cool and all, but until the massive issues with off-target effects are sorted out I can't see it making a huge...
Typo: should read CRISPR, sorry!....
Hi deano1, It's not a six million dollar company. It had 6 million in revenues and the company is EDIT . This is an o...
I just read a Harvard U article on CRISPR which leads to me to believe this thing is moving forward. I own a small, 1.7%...
Here is a basic layman's article on CRISPR. It appears to be well sourced. New CRISPR Tools enable extraordinarily p...
$CRISPR Weekend reading: Researchers use gold nanoparticles to deliver CRISPR-Cas9 and correct a point mutation in a m...
Hi SoGiAM, I have searched up and down the site and don't find a gummy position on CRISPR., gene therapy. EDIT, CRSP, NT...
#crisprgold hashtag on Twitter #XDMD #DMD $SRPT $CAPR zowz news.berkeley.edu/.. Gold nanoparticle used to replace vir...
With relevance to: $SRPT $CAPR $CATB $DMD CRISPR-Gold' Fixes Duchenne Muscular Dystrophy Mutation in Mice (10/4) B...
$Gene Editing $Glaucoma University Of Iowa Researchers Use CRISPR Engineering To Prevent Certain Glaucoma In Mice ...
ZGNX thoughts from Paul Matheis (no opinion from me): Overall belief that risk-reward is good. Quite hopeful the trial...
For those interested in the science behind the discovery and early development of CRISPR-CAS9 gene editing technology, I...
Some form of CRISPR technology will successfully target A disease - not hundreds or thousands. And some CRISPR outfit ...
I can't share any experience with that particular newsletter (I despise $1500/year newsletters in general), but I can sh...
Cellectis Wins CRISPR Patent in Europe Jonathan Wosen, GEN News Highlights, 25 July 2017, http://www.genengnews.com/g...
Headlines & News go t GlobeNewswire 8/22/2017 7:30:00 AM CRISPR Therapeutics Announces Collaboration with Massachu...
Malicious code written into DNA infects the computer that reads it https://techcrunch.com/2017/08/09/malicious-code-wri...
$EDIT np related - RNA-targeting CRISPR could yield treatments for Huntington's, ALS http://www.fiercebiotech.com/resea...
$SGMO xenotransplantation zinc finger gene editing pigs for transplanting organs into human #lung #pancreas #heart #li...
kristilee1 Possible? Probably. You can bet that Fort Dietrich has been working on weaponizing bacteria,,, and virus, ...
there are several companies doing ''gene editing''. CRISPR is one....
$MRTX np, $EPZM np - #Chromatin So much attention for #CRISPR on DNA, but it's also elucidating epigenetics The epig...
$MRK np - CRISPR patent battle in Europe takes a ‘wild’ twist with surprising player http://www.sciencemag.org/news...
#CRISPR #Bioethics -$EDIT np $NTLA np $CLLS long etc... - http://www.spokesman.com/stories/2017/aug/05/the-ethics-of-cr...
I just read that the Dept of Defense is getting involved with CRISPR and the c-9 (sp?) DNA editing process to make sure...
my gut tells me it could be a one of these but Travis or others could help pin point. Editas, (edit) Cymabay (cbay) Inte...
so my gut tells me it could be a one of these but Travis or others could help pin point. Editas, (edit) Cymabay (cbay) I...
This company was heavily teased 2 years ago, when they apparently thought that the patent fight in court would be over q...
#CRISPR - First Human Embryos Edited in U.S. https://www.technologyreview.com/s/608350/first-human-embryos-edited-in-...
Two interesting links from the latest Labiotech.eu newsletter: “Cutting Through the BS in Biopharma: How To Spot Hy...
Some annotations: Mixed emotions on $GNFTF. No position. THIS SPACE IS EVOLVING RAPIDLY and while GenFit's elafibrinor w...
$noticker Boom in human gene editing as 20 CRISPR trials gear up A pioneering CRISPR trial in China will be the first ...
$ EDIT fp Editas Medicine Announces U.S. Patent and Trademark Office Decision Favorable to Broad Institute in CRISPR...
#Zika - Mosquitoes swat back via resistance to CRISPR gene drive http://www.ipscell.com/2017/02/mosquitoes-swat-back-vi...
Mosquitoes swat back via resistance to CRISPR gene drive http://www.ipscell.com/2017/02/mosquitoes-swat-back-via-resist...
Prior post awaiting moderation, but this is timely Starting now Slingshot Insights Expert Interview @ 1PM EST - Join...
Starting in a few minutes Slingshot Insights Expert Interview @ 1PM EST - Join us for an in-depth conversation on CRI...
$EDIT $NTLA $CRSP...np any of 3 CRISPR heavyweights battle in US patent court http://www.nature.com/news/crispr-heavy...